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Abstract Circulating aldosterone levels are increased in
human pregnancy. Inadequately low aldosterone levels as
present in preeclampsia, a life-threatening disease for both
mother and child, are discussed to be involved in its patho-
genesis or severity. Moreover, inactivating polymorphisms
in the aldosterone synthase gene have been detected in
preeclamptic women. Here, we used aldosterone synthase-
deficient (AS−/−) mice to test whether the absence of aldo-
sterone is sufficient to impair pregnancy or even to cause
preeclampsia. AS−/− and AS+/+ females were mated with
AS+/+ and AS−/− males, respectively, always generating
AS+/− offspring. With maternal aldosterone deficiency in
AS−/− mice, systolic blood pressure was low before and
further reduced during pregnancy with no increase in pro-
teinuria. Yet, AS−/− had smaller litters due to loss of fetuses
as indicated by a high number of necrotic placentas with
massive lymphocyte infiltrations at gestational day18.
Surviving fetuses and their placentas from AS−/− females
were smaller. High-salt diet before and during pregnancy
increased systolic blood pressure only before pregnancy in
both genotypes and abolished the difference in blood pres-
sure during late pregnancy. Litter size from AS−/− was
slightly improved and the differences in placental and fetal
weights between AS+/+ and AS−/− mothers disappeared.
Overall, an increased placental efficiency was observed in
both groups paralleled by a normalization of elevated
HIF1α levels in the AS−/− placentas. Our results demon-
strate that aldosterone deficiency has profound adverse
effects on placental function. High dietary salt intake im-
proved placental function. In this animal model, aldosterone
deficiency did not cause preeclampsia.
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Introduction
Pregnancy is characterized by a profound volume expansion
due to high aldosterone levels meant to support fetal well-
being [5]. Preeclampsia is a clinical syndrome in pregnant
women defined as the new onset of hypertension and pro-
teinuria after 20 weeks of gestation. It affects 3–5 % of all
pregnancies and is the leading cause of maternal and fetal
morbidity and mortality [40]. The etiology of preeclampsia
is multifactorial.
Insufficient placental implantation oxidative stress, ge-
netic predisposition, natural killer cell dysfunction, or
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preformed agonistic angiotensin II receptor subtype 1 auto-
antibodies may contribute to the development of preeclamp-
sia [6, 29, 40]. Histologically, preeclampsia is characterized
by a defect in the invasion of the endovascular trophoblast
that may eventually cause reduced blood supply to the
fetoplacental unit [25, 28].
Placental ischemia may trigger the release of vasoactive,
angiogenic, and antiangiogenic factors such as vascular
endothelial growth factor (VEGF) and placental growth
factor as well as an enhanced placental expression of the
angiogenic receptors fms-like tyrosine kinase 1 (Flt-1) and
endoglin [22]. Likewise, their soluble forms soluble fms-
like tyrosine kinase-1 (sFlt-1) and sEng are released into
systemic circulation leading to endothelial dysfunction and
increased blood pressure.
Normal pregnancy is characterized by a marked expan-
sion of plasma and extracellular volume associated with
changes in renal hemodynamics as well as in the circulating
level of adrenal steroid hormones [17, 27], which likely help
adapting the maternal circulation to the increasing blood and
substrate requirements of the growing placenta and fetus.
Consistently, plasma aldosterone concentrations increase
during normal pregnancy coinciding with plasma volume
expansion [33, 38]. In preeclampsia, a reduced plasma vol-
ume precedes the onset of and is consistently reported to be
reduced during the disease associated with a shift of fluid
from intravascular to interstitial space and edema [8, 12, 14,
38] while plasma aldosterone concentration and renin activ-
ity are suppressed [37]. This observation suggested pre-
eclampsia to be caused or aggravated by an inadequate
balance of extracellular volume and the activity of the
renin–angiotensin–aldosterone system. As a substantial
group of preeclamptic women also show reduced aldoste-
rone synthase enzyme (CYP11B2 gene) activity [35], aldo-
sterone deficiency was implicated to play a role in the
pathogenesis of preeclampsia. Aldosterone deficiency may
lower extracellular volume and increase thereby the risk of
placental hypoperfusion [35] thus indirectly causing the re-
lease of vasoactive factors leading to preeclampsia. The pos-
sible role of aldosterone was further evidenced by the finding
that loss and gain of function due to distinct gene variants of
CYP11B2 may predispose for or protect from preeclampsia,
respectively. In fact, the V386Avariant of the CYP11B2 gene,
which causes a deficiency in the rate-limiting step of aldoste-
rone synthesis, the 18-hydroxycorticosterone methyl oxidase
activity [30], was observed solely in a subgroup of preeclamp-
tic women, but never in normal pregnant women [35]. In
contrast, the gain of function variants of the CYP11B2 gene
in the SF-1 and Int2 (C) sites, which have been shown to be
associated with hypertension in non-pregnant subjects [26],
apparently reduce the risk of developing preeclampsia [9].
Recently, observations by Gennari-Moser et al. [16] suggested
a role of aldosterone in fetal perfusion and also in placental
growth. Taken together, these studies propose a role of aldo-
sterone availability for placental size, fetal perfusion, and also
the development of preeclampsia. Whether these effects of
aldosterone are mediated directly via the mineralocorticoid
receptor in placental tissue or more indirectly via the regula-
tion of NaCl homeostasis and blood pressure regulation has
not been fully clarified.
Aldosterone is closely linked to salt uptake. Of interest,
an old clinical study forwards the observation of a reduced
incidence of preeclampsia and fetal death on a high-salt diet
[32]. In addition, in a hypertensive woman homozygous for
the V386A CYP11B2 mutation and low aldosterone avail-
ability salt supplementation lowered systolic blood pressure
(SBP) throughout pregnancy [10]. However, it is not clear
whether aldosterone deficiency alone can lead to preeclamp-
sia and whether aldosterone deficiency can be counterbal-
anced by a high-salt diet.
Thus, we examined whether aldosterone deficiency would
compromise pregnancy and even cause preeclampsia-like
symptoms in mice. Using CYP11B2-deficient mice (AS−/−)
[21], we found that the absence of maternal aldosterone did
not cause proteinuria or arterial hypertension, two major
symptoms of preeclampsia, but reduced litter size due to loss
of fetuses and severe placenta pathologies during the period of
pregnancy. Feeding a high-salt diet during pregnancy partially
rescued this defect suggesting that reduced placental perfusion
may play an important role.
Methods
Animals
All experiments were performed with inbred 129 SvEv
genetic background [24] aldosterone synthase wild type
(AS+/+) and aldosterone synthase-deficient (AS−/−) female
mice. This mouse model was generously provided by Prof.
Oliver Smithies, University of North Carolina, Chapel Hill,
NC, USA [21]. Unless indicated otherwise, animals were
fed standard rodent chow (3430, Kliba Nafag, Kaiseraugst,
Switzerland) with free access to normal tap water. All
experiments were performed according to Swiss Animal
Welfare laws.
Study design and treatment
Age-matched female AS+/+ and AS−/− mice, between 3.5 to
6.5 months old, were used for experiments. Animals were
divided into two groups, a control group and an exper-
imental group. In the control group, AS−/− male were
mated with AS+/+ female mice, whereas in the experi-
mental group, AS+/+ male mice were mated with AS−/−
females to generate only heterozygous pups to have the
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same genotype for all pups. Both groups were fed with
either the standard rodent chow powder, (3433 Kliba
Nafag) containing 0.20 % Na+ and 0.36 % Cl− (control
diet) (AS+/+ n09 and AS−/− mice n09) or with standard
diet supplemented with NaCl (high-salt diet, 5 % NaCl;
AS+/+ n06–8 and AS−/− mice n08–10). To feed the
mice with high-salt diet, 100 g of standard rodent chow
powder was mixed with 5 g NaCl and then mixed with
an equal volume of deionised water to moisten the food
for feeding. Male and female mice were kept together in
individual cages for breeding and female mice were
controlled daily in the early morning for the presence
of copulation plugs and the following day was consid-
ered as gestational day1. SBP was measured in female
mice using the tail cuff method (see below). In another
set of experiments, mice were fed either the control diet
(AS+/+ n08, AS−/− n015) or high-salt diet (5 % NaCl)
(AS+/+ n06, AS−/− n09) and sacrificed on day18 of
pregnancy by cervical dislocation. The number and
weight of pups and placentas were measured, and tis-
sues collected for further analysis. Placentas were col-
lected and rapidly frozen in liquid nitrogen and stored
at −80 °C for RNA extraction. Some placentas were
fixed in 4 % paraformaldehyde for histology.
Tail cuff SBP measurements
SBP was measured by a non-invasive computerized tail cuff
method (BP2000, Visitech Systems, Apex, NC, USA) as
described previously [20]. Mice were adapted for 5 days
before the start of the study. This period of adaption has
been characterized previously for this specific tail cuff meth-
od and found to reduce stress-induced side effects [20].
Blood pressure was measured at the same time everyday
from 1 to 5 pm. Averages of SBP measurements having
standard deviations less than 10 mmHg were considered for
further analysis. Systolic blood pressure from female mice
on control diet was measured on control conditions 2 to
3 days before pregnancy and from day1 of pregnancy until
the end of pregnancy up to 21 days. Mean SBP was calcu-
lated from each day's average SBP measurements. SBP for
high-salt diet experiments was measured on control diet,
then mice were given high-salt and SBP was measured
again after 4 days of high-salt diet. Thereafter, female mice
were kept together with male mice for mating and SBP was
measured at gestational days5 to 7 and 15 to 17. Mean SBP
was calculated from 3 days of average SBP measurements.
Urinary protein concentration measurement
Spot urine was collected from female mice during pregnan-
cy everyday by gentle massage of the urinary bladder. Total
urinary protein concentration was measured with a standard
protein assay kit (Bio-Rad Dc Protein Assay, Bio-Rad,
Hercules, CA, USA). Urinary creatinine concentration was
measured by the Jaffe method [34].
RNA extraction and semi-quantitative real-time PCR
Semi-quantitative real-time polymerase chain reaction (qRT-
PCR) was performed to assess the expression of VEGF,
sFlt-1, the hypoxia-inducible factor 1α (HIF1α), tumor
necrosis factor 1-alpha, and the monocyte chemo-attractant
protein 1 (MCP-1). Snap frozen placentas (five placentas
per group) were homogenized in RLT buffer (Qiagen,
Hilden, Germany) supplemented with 2-mercaptoethanol
to a final concentration of 1 %. Total RNA was extracted
from 200 μl aliquots of each homogenized sample using
RNeasy Mini Kit (Qiagen, Hilden, Germany) according to
the manufacturer's instructions. Quality and concentration of
the isolated RNA preparations were measured on a ND-
1000 spectrophotometer (Thermo Fischer Scientific Inc.,
Wilmington, DE, USA). Total RNA samples were stored
at −80 °C until further use. Each RNA sample was diluted to
100 ng/μl and 3 μl was used as a template for reverse
transcription using the TaqMan Reverse Transcription Kit
(Applied Biosystems, Forster City, CA). Semi-quantitative
real-time (qRT-PCR) was performed on the ABE PRISM
7500 Sequence Detection System (Applied Biosystem,
Foster City, CA, USA). Primers for VEGF, sFlt-1, and the
HIF1α were designed using Primer 3 online software,
whereas primers for hypoxanthine guanine phosphoribosyl
transferase (HPRT) and glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) as housekeeping genes were designed
using Primer Express software from Applied Biosystem.
Sequences of primers are as follows: GAPDH forward 5-
GTCGTGGATCTGACGTGCC-3 ′ and reverse 5 ′-
GATGCCTG CTTCACCACCTT-3′, VEGF forward 5′-
CAGGCTGCTGTAACGATGAA-3′ and reverse 5′-GCA
TTCACATCTGCTGTGCT-3 ′ , sF l t f o rwa rd 5 ′ -
GGGAAGACATCCTTCGGAAGA-3′ and reverse 5′-
TGTGGTACAATCATTCCTCCTG-3′, HIF1α forward 5′-
ATCTCGGCGAAGCAAAGAG and reve r se 5 ′ -
CTGTCTAGACCACCGGCATC-3′, HPRT forward 5′-
TTATCAGACTGAAGAGCTACTGTAAGATC-3 and re-
verse 5′-TTACCAGTGTCAATTATATCTTCAACAATC-
3′. The primers and probes used from Applied Biosystem
are MCP-1 (Mm00441242) and TNFα (Mm99999068).
Specificity of the primers was first tested in a standard
PCR and always resulted in a single product of the expected
size on 2 % agarose gel. Real-time PCR reactions were
performed using the iQ SYBR Green Supermix (Bio-Rad,
Hercules, CA, USA). ROX Passive reference Dye (Bio-Rad,
Hercules, CA, USA) 3.3 μl/1.25 ml of iQ SYBR Green
Supermix was added. Briefly, 3 μl cDNA, 0.8 μl of each
primer (10 μM), 5.4 μl RNase free water, and 10 μl iQ
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SYBR Green Supermix were mixed to 20 μl final reaction
volume. Reaction conditions were: denaturation at 95 °C for
10 min followed by 40 cycles of denaturation at 95 °C for
15 s and annealing/elongation at 60 °C for 60 s followed by
dissociation stage (95 °C for 15 s, 60 °C for 15 s followed
by a slow ramp to 95 °C). All reactions were run in dupli-
cate. The expression of gene of interest was calculated in
relation to HPRT. Relative expression ratios were calculated
as R ¼ 2 Ct HPRT actin=ð Þ Ct testgeneð Þ½ .
Histology
Placentas were fixed by immersion in 4 % paraformalde-
hyde (AppliChem, Darmstadt, Germany). After tissue pro-
cessing and embedding in paraffin, 5-μm sections were
prepared. Paraffin sections were stained with hematoxylin–
eosin (H&E) and scanned with a Mirax Midi Slide Scanner
microscope (Zeiss, Jena, Germany).
Immunoblotting
Placentas, stored at −80 °C, were homogenized in ice-cold
homogenisation buffer [0.27 M sucrose, 2 mM EDTA,
0.5 % NP40 prepared in 1× buffer A supplemented with
protease and phosphatase inhibitor cocktails (Roche,
Mannheim, Germany; buffer A: 0.6 M KCl, 150 mM
NaCl, 150 mM HEPES, pH7.5)]. Homogenates were over-
laid on a sucrose cushion (30 %w/v sucrose, 2 mM EDTA,
pH8 prepared in 1× buffer A) and centrifuged at 3,000 rpm
for 10 min at 4 °C. After centrifugation, supernatant
obtained were stored as a cytoplasmic fraction, and pellets
of nuclei were resuspended in 1× nuclei extraction buffer
(20 mM HEPES, pH7.5, 400 mM NaCl, 1 mM EDTA, pH
8) and incubated for 15 min on ice with intermittent vortex-
ing. Solubilised nucleated pellet fractions were centrifuged
again at 15,000 rpm for 5 min at 4 °C and supernatant
collected as nuclear protein fraction. Protein concentration
was measured by protein assay kit (Bio-Rad protein assay,
Munich, Germany) as per manufactures instructions.
Proteins (60 to 80 μg) were solubilised in 5× Laemmli
sample buffer and run on 8 % polyacrylamide gels.
Briefly, protein was separated by SDS-PAGE, transferred
on nitrocellulose membrane by wet transfer method and
incubated overnight with following primary antibodies: rab-
bit polyclonal anti-HIF1α (1:1,000, Novus Biologicals) and
mouse monoclonal β-actin (1:10,000, Sigma). After wash-
ing, nitrocellulose membranes were incubated with anti-
rabbit secondary fluorescent antibody (goat anti-rabbit
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Fig. 1 SBP, proteinuria, and
litter size on control diet. a SBP
measured during the course of
pregnancy from days0 to 21 in
AS+/+ (n06–9 animals/time
point) and AS−/− (n03–9
animals/time point) dams. b
Urine total protein
concentration normalized to
creatinine concentration
measured from spot urine
during pregnancy in AS+/+
(n08) and AS−/− dams (n06). c
Number of pups counted on the
day of delivery in AS+/+ (n09)
and AS−/− (n09) dams. Values
are means ± SEM. *P<0.05,
**P<0.005, ***P<0.001 vs.
AS+/+
334 Pflugers Arch - Eur J Physiol (2012) 464:331–343
IRDye 800 1:10,000 or goat anti-mouse IRDye 680
1:20,000, Li-COR, Nebraska, USA). After washing the
membranes three times, the protein signal was detected by
scanning the membrane with the Odyssey Infrared Imaging
System (Li-COR Biosciences). All images were analyzed
using analysis software provided with the system to calcu-
late the protein of interest/actin ratio.
Statistical analysis
Results are expressed as mean ± SEM. All data were tested
for significance using paired or unpaired Student's test, one-
or two-way ANOVA analysis followed by Tukey's multiple
comparison post-test where appropriate. P<0.05 was con-
sidered statistically significant.
Results
Absence of a maternal preeclamptic phenotype
in AS−/− mice during pregnancy
To test the hypothesis that aldosterone deficiency during preg-
nancy may contribute to the pathogenesis of preeclampsia, we
measured SBP and urinary protein excretion in AS+/+ and
AS−/− dams before and during pregnancy. In order to eliminate
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Fig. 2 Litter size, litter and
placental weights, and healthy
and necrotic placentas in AS+/+
and AS−/− dams on day18 of
pregnancy. a Number of fetuses
and necrotic placentas were
counted in the uterus from
AS+/+ (n0 total number of
fetuses and placentas from eight
females) and AS−/− dams
(n0 total number of fetuses and
placentas from 15 females). b
Photos of fetuses and placentas
in the uterus from AS+/+ and
AS−/− dams and comparison of
healthy and necrotic placenta. c
Mean litter and mean placental
weight versus litter size in
AS+/+ (n08 litters) and AS−/−
dams (n012 litters). Values are
means ± SEM. **P<0.005,
***P<0.001 vs. AS+/+
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the genotype of the fetuses as confounding factor, AS+/+
females were mated to AS−/− males and AS−/− females to
AS+/+ males producing only AS+/− offspring. Before and
during pregnancy, SBP was significantly higher in AS+/+ than
in AS−/− dams (Fig. 1a). While blood pressure of AS+/+
remained constant at about 110 mmHg throughout pregnancy,
SBP in AS−/− dams decreased from about 105 mmHg at day1
to about 90 mmHg at day21. Importantly, there was no
difference in urinary protein excretion and no increase in
AS+/+ and AS−/− mice during pregnancy (Fig. 1b). Thus,
AS−/− dams did not become hypertensive and did not develop
proteinuria during pregnancy.
Presence of a fetoplacental phenotype in AS−/− mice
on control diet
Mean litter size at birth was lowered in AS−/− dams com-
pared to AS+/+ mice (3.0±0.55 vs. 6.22±0.66, respectively;
p<0.005) representing a strong fetal phenotype (Fig. 1c). To
examine whether the reduced litter size at birth was due to
A
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#
* *
+/+
Normal
-/-
Normal
-/-
Necrotic
B
* #
BDBD DBJZLZ JZ ZLZL
Fig. 3 Histology of placentas. a Cross-section and HE stain of a
placenta from an AS+/+ dam, and healthy and necrotic placentas from
AS−/− dams. Bar02,000 μM. b Higher magnification of boxed area
from a. Bar0200 μM. DB0decidua basalis, JZ0 junctional zone, and
LZ0 labyrinth zone. Asterisk indicates lymphocyte infiltration and
number sign indicates coagulative necrosis
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intrauterine death of fetuses, dams were sacrificed on gesta-
tional day18 (E18) and the number and weight of fetuses
and placentas were measured. The mean litter size was again
smaller in AS−/− compared to AS+/+ dams (2.67±0.54 vs.
7.13±0.48, respectively; p<0.0001; Fig. 2a). The reduction
of the number of pups paralleled the presence of dark and
necrotic placentas in AS−/− mice (Fig. 2a, b). Necrotic
placentas were mostly observed in series next to each other
but sometimes also observed interspersed between healthy
placentas. Necrotic placentas were not seen in any AS+/+
dams on control diet.
When the mean litter and placental weights were plotted
against litter sizes (Fig. 2c), it became evident that the data
for the AS−/− mice were not only shifted to smaller litter
sizes but also to reduced litter and placental weights. This is
most evident when litters of the same sizes in AS−/− and in
AS+/+ are compared (i.e., litter sizes of five and seven pups
in Fig. 2c). In contrast, in very small litters (n01–3), pla-
cental weight appeared to be normal. Histological examina-
tion of the placentas further confirmed the reduced size of
placentas in AS−/− dams, but did also reveal that most of the
placentas were otherwise healthy with a similar structural
organization of decidua basalis, junctional zone, and laby-
rinth as in AS+/+ dams (Fig. 3a, b, left and middle section).
Only dark placentas from AS−/− dams showed severe coag-
ulative necrosis with lymphocyte infiltrations in all three
layers of the placenta (Fig. 3a, b; right section).
High-salt diet does not increase intrauterine survival,
but improves fetal growth in AS−/− mice and lowers SBP
irrespective of the presence of aldosterone
Hypothesizing that aldosterone deficiency in AS−/− mice
might compromise placental perfusion, we tested if replac-
ing renal sodium losses by feeding a high-salt diet (5 %
NaCl) before and during pregnancy may improve SBP, the
weight of placentas and pups, and litter sizes. AS+/+ and
AS−/− females were fed a high-salt diet starting 12 days
before until the end of pregnancy. After 4 days on a high-
salt diet, SBP rose in both groups of mice, but this increase
occurred in parallel and hence AS−/− female mice continued
to have lower SBP than AS+/+ female mice (Fig. 4a). During
the first days (days5–7) of pregnancy, SBP dropped signifi-
cantly in both AS+/+ and AS−/− dams, but the decrease of SBP
was much more pronounced in AS+/+ mice than in AS−/−
mice. Therefore, the SBP difference between genotypes be-
came very small (days5–7) and was no longer significant on
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control and −10 to −8 for high salt), at gestational days5 to 7 and 15 to
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days15 to 17. This is in contrast to the measurements in dams
on standard chow, where a significant difference in SBP was
maintained throughout the entire pregnancy (Fig. 1). In AS−/−,
blood pressure was lower towards the end of gestation irre-
spective of salt intake (Fig. 4b). In AS+/+ mice, SBP did not
drop significantly in pregnancy on a normal salt diet.
However, if a high-salt diet was provided, blood pressure
dropped reaching the lowest levels at the end of pregnancy
(Fig. 4c). Of interest, both a low- and a high-volume state led
to a blood pressure reduction in pregnancy with the latter
being even more consistent throughout pregnancy.
The high Na+ diet did neither increase the mean litter size
nor decrease the number of necrotic placentas in AS−/− dams
(Fig. 5a). However, the mean weights of litters and placentas
were no longer different between the genotypes when litters
of the same sizes were compared (Fig. 5b). This contrasts
with the standard salt intake, when both mean litter and
placental weights were smaller in AS−/− than in AS+/+ dams
(Fig. 2c). Thus high-salt intake does not increase the sur-
vival rate of fetuses, but appears to improve intrauterine
growth of surviving pups.
The beneficial effect of a high-salt intake was seen for
both genotypes. Although the 5 % NaCl intake did not
increase mean placental weight, it significantly improved
the weight of the fetuses in AS+/+ and AS−/− dams (Fig. 6a,
b). Consistent with these differential effects on fetal and
placental growth, placental efficiency (ratio of fetal weight
over placental weight) was significantly increased in both
AS+/+ and AS−/− dams on high-salt diet compared to control
diet (Fig. 6c). Interestingly, placental efficiency was not
significantly different between AS+/+ and AS−/− dams, nei-
ther on control nor on high-salt diet (Fig. 6c).
Expression of the hypoxia-inducible factor HIF1α
in placentas
Preeclampsia is associated with altered expression of key
anti- and pro-angiogenic factors [40]. We did not detect any
differences in the mRNA expression of HIF1α (Fig. 7a),
VEGF (Fig. 7b), and sFlt (Fig. 7c) between healthy appear-
ing placentas from AS+/+ and AS−/− dams kept on either a
control or a high-salt diet. Since HIF1α is mostly regulated
at the post-translational level by stabilization and degrada-
tion of the protein, we performed immunoblots. HIF1α
protein abundance was significantly increased in healthy
placentas from AS−/− dams on control diet (Fig. 8a). This
difference disappeared on high-salt diet (Fig. 8b). HIF1α
protein was not detected in necrotic placentas (Fig. 8a).
Expression of pro-inflammatory factors in necrotic
placentas
The MCP-1 and TNFα are key pro-inflammatory cytokines
involved in inflammatory process. Expression of MCP-1
and TNFα mRNA was significantly increased in necrotic
placentas from AS−/− dams on control (Fig. 9a) and high-salt
diet (Fig. 9b) but not in healthy-appearing placentas from
both genotypes.
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Discussion
Plasma volume expansion in the presence of high aldoste-
rone levels is considered crucial for healthy pregnancies,
both of which are low in the most severe form of hyperten-
sive pregnancies, preeclampsia. In order to examine the role
of aldosterone in the development of preeclampsia, we used
an aldosterone synthase knockout mouse model (AS−/−).
AS−/− mice have a compensatory increase of renin and
angiotensin II to supraphysiological concentrations but no
aldosterone [21] allowing to independently test the role of
aldosterone in pregnancy. Additional effects of these high
renin and angiotensin II may occur but could not be tested
because survival of AS−/− mice depends on high angiotensin
II levels and pharmacological blockade of AT1 receptors is
lethal in AS−/− mice (unpublished observations).
New-onset hypertension and proteinuria with fetoplacen-
tal developmental disturbances are considered to be cardinal
features of preeclampsia [40]. We found that AS−/− dams did
not develop preeclampsia as suggested by the absence of
hypertension and proteinuria during pregnancy. A previous
study measured SBP by telemetry during pregnancy and
showed no change in SBP during the first 5 days, followed
by a drop in SBP from days6 to12, and again from days15
to 17 of pregnancy [4]. In our hands, using the less sensitive
tail cuff method, we found reduced SBP in wild-type mice
during pregnancy in response to salt loading. Though contra-
intuitive, this observation is in line with some clinical obser-
vations during salt loading in pregnancy suggesting a benefi-
cial systemic feedback on maternal hemodynamics upon
optimal placental perfusion [10, 32]. Thus, preeclampsia is
not caused by a lack of aldosterone alone, at least in mice.
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However, the mouse model revealed a number of other
interesting observations demonstrating an important role of
aldosterone in normal pregnancy. AS−/− dams were hypoten-
sive before pregnancy and became even more hypotensive
during mid to term pregnancy. The resulting fetoplacental
phenotype of a decreased litter size and smaller or necrotic
placentas without fetuses at term suggests a severe placental
hypoperfusion. The sum of intact fetuses and necrotic pla-
centas in AS−/− mice was similar to the average number of
fetuses in AS+/+ dams, indicating that AS−/− damswere able to
conceive normally but had impaired placental development
and function, predisposing to intrauterine death. The few
normal weight placentas and fetuses observed in AS−/− dams
carrying small litters would such provide a residual blood and
nutrient supply to the remaining placentas.
Histological examination of healthy placentas from AS−/−
dams demonstrated normal structural patterns but reduced
size. One important reason for lower placental weight might
be the absence of direct effects of aldosterone on the pla-
centa in AS−/− dams. In vitro experiments have revealed a
direct role for aldosterone in the modulation of trophoblast
growth and placental size [16] and in vivo studies in ewes
suggested a role of aldosterone in placental growth [19].
Placental size in rats and humans is positively correlated
with plasma levels of aldosterone [16]. Thus, aldosterone
may positively modulate placental growth, similar to its
proliferative capabilities in organs such as the heart and
the kidney [36, 39].
Reduced fetal weight in AS−/− dams might thus be due to
placental insufficiency. In normal human pregnancy, plasma
volume expansion is associated with increased plasma aldo-
sterone level, whereas both were decreased in pregnancies
with intrauterine growth restriction and preeclampsia [33].
Preeclampsia is characterized by extracellular volume ex-
pansion but low intravascular volume which is caused at
least in part by a shift of fluid from the intravascular to the
interstitial fluid space due to vasoconstriction and leaky
endothelium [12, 13, 31]. Lack of aldosterone in AS−/−
dams might thus critically impair plasma volume expansion
and thereby cause reduced uterine blood supply similar to
functional aldosterone deficiency in mice chronically ex-
posed to the mineralcorticoid receptor antagonist spirono-
lactone during pregnancy which led to reduced fetal
umbilical blood flow [16]. Moreover, modeling a reduced
uterine blood supply by constriction of the uterine artery in
rats from gestational day14 caused placental insufficiency
resulting in low-birth weight [2].
One common cause for the decreased litter size, reduced
fetal and placental weights, and necrotic and inflammatory
placentas in AS−/− dams could be hypoxia. In rats, hypoxia
during the last 11 days of pregnancy results in smaller-sized
litters, decreased placental and fetal weights, and placental
resorption [18]. Low oxygen tension affects cytotrophoblast
proliferation and invasion and ultimately fetal growth [15].
Consistently, the hypoxia-induced factor HIF1α, a master
regulator in the adaption to hypoxia, is essential for mam-
malian placentation [1]. HIF1α protein abundance was sig-
nificantly higher in AS−/− mice on control diet, but was
reduced to control levels on 5 % NaCl diet in the normal-
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appearing placentas suggesting hypoxia and rescue by high
NaCl intake. Consequently, AS−/− necrotic placentas
showed coagulative necrosis and severe lymphocyte infil-
tration and elevated levels of proinflammatory cytokines
MCP-1 and TNFα.
Aldosterone plays a central role in the long-term control
of extracellular volume by adapting renal and extrarenal
reabsorption of sodium to blood pressure [3]. Thereby,
extracellular NaCl and volume is enlarged; blood pressure
and organ perfusion is increased. AS−/− mice are hypoten-
sive despite highly elevated levels of renin and angiotensin
II. High-salt diet reverses renin and angiotensin II abnor-
malities without increasing blood pressure indicating that
the extracellular volume status is at least partially normal-
ized [23]. To rescue the possibly reduced plasma volume
and lower uterine blood flow in AS−/− dams, we treated
mice with high salt for 12 days before pregnancy until
gestational day18. Both AS+/+ and AS−/− mice responded
by increasing SBP suggesting that AS−/− dams also retained
salt and fluid even though plasma volume was not directly
measured.
High-salt diet had several interesting implications. Next
to the blood pressure lowering potency in pregnant wild-
type mice, it partially rescued the fetal phenotype with a
substantial effect on fetal weight, placental hypoxia, and
placental efficiency in both AS+/+ and AS−/− dams.
Placental efficiency can be altered experimentally by manip-
ulation of uterine blood flow, oxygen availability, and by the
intake and composition of maternal diet. Increased efficien-
cy is also seen in naturally small relative to large placentas
in pigs, sheep, goats, rats, and mice. Placental efficiency in
these polytocous species is positively related to litter size
[11]. We found that smaller placentas in AS+/+ dams on
high-salt diet and AS−/− dams were associated with larger
litter size indicating positive correlation between placen-
tal efficiency and litter size. Decreased placental weight
with larger litter size in AS+/+ dams on high-salt diet
also suggests increased placental efficiency thus sup-
porting an unrestricted fetal growth. While small, dark
placentas were still observed in AS−/− dams on high-salt
diet similar to control diet it remains amenable a con-
sequence of altered local aldosterone availability to sup-
port placental development.
Limitations of this model of aldosterone deficiency are
the high renin and angiotensin II levels which may trigger
local dysregulatory events in preeclampsia. In the absence
of aldosterone synthase, deoxycorticosterone, corticoste-
rone, and some 18-hydroxycorticosterone are still synthe-
sized via 11β-hydroxylase activity. Thus, the life-long
inhibition of aldosterone synthesis in these animals poten-
tially allowing for alternative mineralocorticoid active ste-
roid hormones might have supplemented some extrarenal
aldosterone effects or even enhanced the inhibition of
proliferation of trophoblasts via the activation of glucocor-
ticoid receptors.
Aldosterone availability appears to be an important prereq-
uisite to support normal fetoplacental development. AS−/−
dams had a fetoplacental phenotype with decreased litter size,
smaller placentas and fetuses, yet no overt preeclampsia. In
the absence of aldosterone, the fetal phenotype might be
rescued in part by high-salt diet. In wild-type mice, the high-
salt diet led to profound blood pressure reduction in pregnancy
which suggests an important role of plasma volume and
placental perfusion for maternal well-being. Thus, the absence
of aldosterone cannot trigger preeclampsia-like symptoms in
mice, but might well contribute to the development of
preeclampsia-related intrauterine growth restriction while pre-
eclampsia needs to be triggered by additional factors. Thus,
our study supports the importance of aldosterone in placental
function in vivo and a possible role for high-salt supplemen-
tation in pregnancies specifically associated with hypoaldos-
teronism or reduced plasma volume expansion to maintain
fetoplacental integrity. In contrast, in preeclampsia, the bene-
fits of salt supplementation are still controversial and have no
major impact on outcome as indicated by a recent meta-
analysis [7].
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